While much is known about the prevalence and associated harms of prescription opioid and benzodiazepine misuse, knowledge is still emerging about other prescription drug misuse. More recently the spotlight has been on second generation antipsychotics such as quetiapine, prescription stimulants and pregabalin. This presentation will examine what is currently know about the prevalence, population characteristics […]

The theme of the 2022 Frontline Mental Health Conference is Working together - Exploring an integrated health wellbeing approach. The conference will provide delegates the opportunity to share their approach to greater frontline mental health care, including: current mental health care practices in your organisation research findings from enquiries, reports, and agency surveys frontline leadership lived-experience learnings gaps […]

Gain advanced clinical practice skills in working with families  Work more effectively with families and carers of people who use alcohol and other drugs, whether the person using drugs is in treatment or not. This workshop focuses on the impact of alcohol and other drugs on families and models of responding using principles of Jim […]

This seminar will report on the findings of the CoLAB qualitative study which aimed to examine the multiple social, material and temporal effects of extended-release buprenorphine depot (BUP-XR) treatment in clients’ lives, among a group of participants receiving BUP-XR in Australia, and consider the situated potentials of these new opioid agonist treatment technologies. In particular, […]

Prenatal drug exposure is one of the fastest growing public health problems in the world. A great deal of attention is focused on treating the infant's withdrawal after birth and reducing duration of hospitalisation but emerging evidence shows that later problems, such as increased risk of death, disability and intra-generational disadvantage. The focus on identifying, […]